MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches
At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered around preparing for drug launches in the current pharmaceutical landscape. While many important topics were covered, a critical element that was notably missing from the discussion was the need for a strategic north star—a guiding philosophy that ensures all tactical…...
Read MoreTop Stories
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Filter
Pharma, Physician, and Patient Pain Points Regarding Clinical Trials
Pharma, physicians, and patients consistently face challenges related to clinical trials. Here's a quick look...
Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?
A majority of patients feel lay summaries for clinical trials are very important and won’t...
Using Digital Enhancements to Maximize Engagement: How Are Pharma and Publishers Embracing Digital?
Best practices to implement digital enhancements and measure effectiveness...
Simplifying the Omnichannel Publication Planning Approach
While the pharma and publication industries use multiple channels like emails, social media, conferences, and...
3 Factors That Will Help Pharma Build Public Trust
Pharma must engage with patients at all levels to build public trust...
Publication Planning Training for Regional Medical Affairs Team
How a global pharma company overcame challenges of integration with regional teams in terms of...